ULTRAVEX-S3 CREAM 10G
₹246.00 Original price was: ₹246.00.₹221.40Current price is: ₹221.40.
Ultravex-S3 Cream is a 10g topical solution that combines Salicylic Acid and Halobetasol Propionate for the treatment of skin conditions such as psoriasis and eczema.
Description
Ultravex-S3 Cream 10g is a topical medication that combines the powerful ingredients of Salicylic Acid and Halobetasol Propionate. Salicylic Acid is a keratolytic agent that helps to exfoliate the skin and remove dead cells, while Halobetasol Propionate is a potent corticosteroid that helps to reduce inflammation and alleviate symptoms of various skin conditions. This cream is specifically formulated to treat skin conditions such as psoriasis, atopic dermatitis, eczema, and other hyperkeratotic skin disorders. It provides relief from itching, inflammation, redness, and scaling associated with these conditions. The combined action of Salicylic Acid and Halobetasol Propionate helps to soothe the skin, promote healing, and restore its normal appearance. It is important to follow the instructions carefully and avoid using this cream on open wounds or broken skin.
Additional information
| Weight | 0.025 g |
|---|---|
| Dimensions | 0.0 × 0.0 × 0.0 cm |
| Category | DERMATOLOGICAL |
| Sub Category | TOPICAL STEROIDS |
| HSN Code | 30049099 |
| Pack Size | 1 |
| Minimum Quantity | 1 |
| Maximum Quantity | 1 |
| Manufacturer | DR REDDY`S LABORATORY |
Note: The actual product packaging may vary slightly from the images shown on our website. Due to manufacturer updates, there may be variations in packaging design. We strive to provide accurate representations of all products.
Related products
-
Sale!

OZABELLE CREAM
₹523.00Original price was: ₹523.00.₹470.70Current price is: ₹470.70. -
Sale!

EUREGA SYRUP
₹125.00Original price was: ₹125.00.₹112.50Current price is: ₹112.50. -
Sale!

ACILOC 300MG TAB
₹60.00Original price was: ₹60.00.₹54.00Current price is: ₹54.00. -
Sale!

ACTIFED DM 100ML LIQUID
₹66.10Original price was: ₹66.10.₹59.49Current price is: ₹59.49.




